Obesity affects approximately 42% of adults in the US. Multiple strategies are available to treat obesity, including behavior therapies, GLP-1 receptor agonists, and bariatric surgery. Therapies vary in effectiveness and risks. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses evidence-based obesity treatment with Melanie Jay, MD, MS, New York University Grossman School of Medicine. Related Content:

• Obesity Management in Adults
• As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging
• FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management